AMPK control of myocardial fatty acid metabolism fluctuates with the intensity of insulin-deficient diabetes.

[1]  A. Bonen,et al.  Contraction-induced fatty acid translocase/CD36 translocation in rat cardiac myocytes is mediated through AMP-activated protein kinase signaling. , 2003, Diabetes.

[2]  Sanjoy Ghosh,et al.  Brief episode of STZ-induced hyperglycemia produces cardiac abnormalities in rats fed a diet rich in n-6 PUFA. , 2004, American journal of physiology. Heart and circulatory physiology.

[3]  J. Dyck,et al.  Activation of cardiac AMP-activated protein kinase by LKB1 expression or chemical hypoxia is blunted by increased Akt activity. , 2006, American journal of physiology. Heart and circulatory physiology.

[4]  G. Shulman,et al.  Physiological role of AMP-activated protein kinase in the heart: graded activation during exercise. , 2003, American journal of physiology. Endocrinology and metabolism.

[5]  J. Auwerx,et al.  Coordinate Regulation of the Expression of the Fatty Acid Transport Protein and Acyl-CoA Synthetase Genes by PPARα and PPARγ Activators* , 1997, The Journal of Biological Chemistry.

[6]  D. Kelly,et al.  Fatty Acids Activate Transcription of the Muscle Carnitine Palmitoyltransferase I Gene in Cardiac Myocytes via the Peroxisome Proliferator-activated Receptor α* , 1998, The Journal of Biological Chemistry.

[7]  David Carling,et al.  Covalent activation of heart AMP-activated protein kinase in response to physiological concentrations of long-chain fatty acids. , 2004, European journal of biochemistry.

[8]  L. Bertrand,et al.  Insulin antagonizes AMP‐activated protein kinase activation by ischemia or anoxia in rat hearts, without affecting total adenine nucleotides , 2001, FEBS letters.

[9]  C. Folmes,et al.  Fatty Acids Attenuate Insulin Regulation of 5′-AMP–Activated Protein Kinase and Insulin Cardioprotection After Ischemia , 2006, Circulation research.

[10]  Sanjoy Ghosh,et al.  The metabolic "switch" AMPK regulates cardiac heparin-releasable lipoprotein lipase. , 2005, American journal of physiology. Endocrinology and metabolism.

[11]  R. Unger,et al.  Role of PP2C in cardiac lipid accumulation in obese rodents and its prevention by troglitazone. , 2005, American journal of physiology. Endocrinology and metabolism.

[12]  D. Hardie.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status , 2022 .

[13]  William C Stanley,et al.  Myocardial substrate metabolism in the normal and failing heart. , 2005, Physiological reviews.

[14]  L. Witters,et al.  Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. , 1996, Biochimica et biophysica acta.

[15]  D. Vertommen,et al.  Activation of AMP-Activated Protein Kinase Leads to the Phosphorylation of Elongation Factor 2 and an Inhibition of Protein Synthesis , 2002, Current Biology.

[16]  D. Hardie,et al.  AMP-activated protein kinase: ancient energy gauge provides clues to modern understanding of metabolism. , 2005, Cell metabolism.

[17]  I. Shiojima,et al.  Akt Activity Negatively Regulates Phosphorylation of AMP-activated Protein Kinase in the Heart* , 2003, Journal of Biological Chemistry.

[18]  S. Cuzzocrea,et al.  Hyperglycemia in streptozotocin-induced diabetic rat increases infarct size associated with low levels of myocardial HO-1 during ischemia/reperfusion. , 2005, Diabetes.

[19]  N. Fujii,et al.  Glucose Metabolism and Energy Homeostasis in Mouse Hearts Overexpressing Dominant Negative α2 Subunit of AMP-activated Protein Kinase* , 2003, Journal of Biological Chemistry.

[20]  G. Lopaschuk,et al.  High Rates of Fatty Acid Oxidation during Reperfusion of Ischemic Hearts Are Associated with a Decrease in Malonyl-CoA Levels Due to an Increase in 5′-AMP-activated Protein Kinase Inhibition of Acetyl-CoA Carboxylase (*) , 1995, The Journal of Biological Chemistry.

[21]  G. Lopaschuk,et al.  Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. , 2000, American journal of physiology. Heart and circulatory physiology.

[22]  E. Taylor,et al.  Long-chain acyl-CoA esters inhibit phosphorylation of AMP-activated protein kinase at threonine-172 by LKB1/STRAD/MO25. , 2005, American journal of physiology. Endocrinology and metabolism.

[23]  M. Birnbaum,et al.  AMP-activated protein kinase mediates ischemic glucose uptake and prevents postischemic cardiac dysfunction, apoptosis, and injury. , 2004, The Journal of clinical investigation.

[24]  L. Witters,et al.  Acetyl-CoA carboxylase regulation of fatty acid oxidation in the heart. , 1993, The Journal of biological chemistry.

[25]  J. Reddy,et al.  Identification of a Peroxisome Proliferator-responsive Element Upstream of the Human Peroxisomal Fatty Acyl Coenzyme A Oxidase Gene (*) , 1996, The Journal of Biological Chemistry.

[26]  Peter J. Brown,et al.  Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ , 1997 .

[27]  D. Carling,et al.  Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia , 2000, Current Biology.

[28]  B. Rodrigues,et al.  The diabetic heart: metabolic causes for the development of a cardiomyopathy. , 1992, Cardiovascular research.

[29]  B. Rodrigues,et al.  Localization of lipoprotein lipase in the diabetic heart: regulation by acute changes in insulin. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[30]  N. Fujii,et al.  Activation of AMP-Activated Protein Kinase as a Unifying Coupling Mechanism , 2000 .

[31]  Sanjoy Ghosh,et al.  Evidence for rapid "metabolic switching" through lipoprotein lipase occupation of endothelial-binding sites. , 2003, Journal of molecular and cellular cardiology.

[32]  J. Huss,et al.  Nuclear receptor signaling and cardiac energetics. , 2004, Circulation research.

[33]  Xianlin Han,et al.  The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. , 2002, The Journal of clinical investigation.

[34]  E. Newsholme,et al.  The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. , 1963, Lancet.

[35]  H. Taegtmeyer,et al.  Streptozotocin-induced changes in cardiac gene expression in the absence of severe contractile dysfunction. , 2000, Journal of molecular and cellular cardiology.

[36]  G. Lopaschuk,et al.  Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. , 2003, American journal of physiology. Endocrinology and metabolism.

[37]  A. Jaffe,et al.  The effect of diabetes mellitus on prognosis and serial left ventricular function after acute myocardial infarction: contribution of both coronary disease and diastolic left ventricular dysfunction to the adverse prognosis. The MILIS Study Group. , 1989, Journal of the American College of Cardiology.